3rd International Caparica Conference in Antibiotic Resistance 2019

10th – 13th June 2019 | Caparica | Portugal

Dear Colleagues and friends

It is with great pleasure that we announce the upcoming international conference on Antibiotic Resistance, to be held in the Caparica, Portugal on 10-13 June 2019.

In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary.

The use of antibiotics constitutes an important factor for selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility in therapeutic failure.

Appearance of multiresistant bacteria is probably accompanied by co-contamination of the environment, leading to a major clinical and public health concern within the lifetime of most people living today. The extensive use has heightened concerns about the expression of antimicrobial resistance, which impacts human and animal safety, food safety and environmental exposure. Antibiotic resistance is an emergent problem, and for this reason the WHO appealed for an urgent and concerted action by governments, health professionals, industry, civil society and patients to slow down the spread of drug resistance, limit its impact today and preserve medical advances for future generations. In the latest years much investigation was developed to understand the emergence of the resistance genes and their spread but this fact does not let us to control totally this problem. In this conference an attempt has been made to present the latest research on possibilities to manage this question.

The primary objective of this meeting is to bring together researchers involved in antibiotic resistance prevention and control. The meeting will take an integrated approach to research and it will bring about researchers specializing in different subjects related to antibiotic resistance. We expected to present a universal vision of the importance of antimicrobial resistance in different ecosystems and what can be done about it.

During diverse sessions, all aspects related to epidemiology of resistance in animal and zoonotic pathogens, mobile elements containing resistance genes, proteomics of antimicrobial resistance, emerging antimicrobial resistance mechanisms, control of resistant infections, antimicrobial resistance in animal pathogens and its exchange with humans, organizing antibiotic surveillance, policies to stimulate drug development and discovery and alternatives strategies to overcome the problem of antimicrobial resistance worldwide will be discussed.

Yours truly
J. L. Capelo

C. Lodeiro
Conference chairs
On behalf of the organizing and scientific committee

Plenary Speakers

Karen Bush, PhD

Affiliation: Indiana University Bloomington (USA)

Title: How Pharma has Responded to the Explosion of New Beta-Lactamases

Fred Tenover, PhD

Affiliation: Vice President, Scientific Affairs Cepheid (USA)

Title: Molecular Diagnostics for Antimicrobial Resistance to Improve Antimicrobial Stewardship

David Livermore, PhD

Affiliation: Norwich Medical School, University of East Anglia, Norwich (UK)

Title: Contending with the Black Swans of Resistance

Patrice Courvalin, PhD

Affiliation: Department of Microbiology, Institut Pasteur (France)

Title: Aminoglycoside resistance by target modification

Christina Vandenbroucke-Grauls, PhD

Affiliation: VU University Medical Center (The Netherlands)

Ana Gales, PhD

Affiliation: Escola Paulista de Medicina/Universidade Federal de São Paulo, São Paulo (Brazil)

Tim Tolker-Nielsen, PhD


Affiliation: Faculty of Health and Medical Sciences, University of Copenhagen (Denmark)

Title: Biofilm-associated antimicrobial tolerance

KPRK Talks

Eric Brown, PhD

Affiliation: M.G. DeGroote Institute for Infectious Disease Research, McMaster University (Canada)

Title: Pushing the envelope in Gram-negative bacteria

David Paul Nicolau, PharmD, FCCP, FIDSA

Affiliation: Center for Anti-Infective Research & Development Hartford Hospital (USA)

Keynote Speakers

Marilyn C. Roberts, PhD

Affiliation: Department of Environmental and Occupational Health Sciences, University of Washington, Washington (USA)

Laurent Poirel, PhD

Affiliation: University of Fribourg, Medical Department, Fribourg (Switzerland)

Albert Berghuis, PhD

Affiliation: McGill University (Canada)

Title: Why even the newest antibiotics stop working

Patrícia Poeta, PhD

Affiliation: Head of Medical Microbiology Laboratory | Applied Biomolecular Sciences (LAQV) – REQUIMTE | Veterinary Science Department, School of Agrarian and Veterinary Sciences, University of Trás-os-Montes and Alto Douro, Vila Real (Portugal)

Title: Dalbavancin as a drug to combat resistant Gram- positive biofilms in osteomyelitis in rats

Tatiana Pinto, PhD

Affiliation: Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro (Brazil)

Title: Evolution of macrolide resistance among Streptococcus pneumoniae strains in Brazil: 1988 to 2015 with PCV10 in between

Aharon Gedanken, PhD

Affiliation: Bar-Ilan University (Israel)

Teresa Coque, PhD

Affiliation: Hospital Ramon y Cajal (Spain)

Johann Pitout, PhD

Affiliation: Dept of Pathology and Lab Medicine, University of Calgary (Canada)

Title: The role mobile genetic elements in the global spread of carbapenemases

Robert Hodges, PhD

Affiliation: University of Colorado (USA)

Title: On the Road to Commercialization of Antimicrobial Peptides to Treat Gram-negative Bacterial Infections

Symposium Subjects

  • Rise of Antimicrobial Resistance and Epidemiology: Concerns on Pathogen Resistance and Public Health
  • A public health approach to antimicrobial Resistance
  • Genetics of antimicrobial resistance
  • Proteomics of antimicrobial resistance
  • The emergence of antimicrobial resistance in animals
  • Antimicrobial resistance in animal pathogens and its exchange with humans
  • How antimicrobial resistance may be affected by the use of antibiotics in food and agriculture
  • Mechanisms of Antibacterial Resistance
  • Organizing antibiotic surveillance
  • Policies to stimulate drug development and discovery
  • Alternative Strategies to overcome the problem of antimicrobial resistance worldwide
  • Control of resistant infections

Hotel Aldeia dos Capuchos

Be aware of cold calls from Convention Hotel Services (CHS) or from someone named Adam Max! A company called CHS (Convention Hotel Services) is calling or e-mailing attendees of conferences worldwide, claiming to work for the conference organizers and asking for credit card details to finalize the booking of accommodation. If you receive such a call or e-mail, do not give away any personal information or credit card details! None of the parties involved in the organization of IC2AR 2019 is working with CHS

We look forward to seeing you soon.

With kindest regards